(Q36699417)

English

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure

scientific article published on September 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Benazepril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and congestive heart failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

0 references

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Balfour JA

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Goa KL

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

1 September 1991

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

511-539

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-199142030-00008

0 references

Determination of the angiotensin converting enzyme inhibitor benazeprilat in plasma and urine by an enzymic method

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of salt balance on the renal and hemodynamic actions of benazepril in normal men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of benazeprilat on left ventricular systolic and diastolic function and neurohumoral status in patients with ischemic heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of ACE inhibition in normotensive patients with chronic glomerular disease and normal renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cilazapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term therapy with benazepril in patients with congestive heart failure: effects on clinical status and exercise tolerance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive mechanism of action of the novel angiotensin converting enzyme inhibitor benazepril. Effect on isolated vascular preparations

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety and tolerability of lisinopril in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of the angiotensin converting enzyme inhibitor benazepril.HCl (CGS 14 824 A) in healthy volunteers after single and repeated administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteinuria in IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diurnal blood pressure in patients with mild-to-moderate hypertension treated with once-daily benazepril hydrochloride

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Responses to captopril and hydrochlorothiazide in black patients with hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of hepatic cirrhosis on the pharmacokinetics of benazepril hydrochloride

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors affecting progression of renal failure in patients on long-term dietary protein restriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction between furosemide and the converting enzyme inhibitor benazepril in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Crossover design for the dose determination of an angiotensin converting enzyme inhibitor in hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of benazepril, a converting enzyme inhibitor, on plasma levels and activity of acenocoumarol and warfarin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme inhibitors of the renin-angiotensin system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of angiotensin converting enzyme (ACE) in plasma and tissues: studies ex vivo after administration of ACE inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ramipril. A review of its pharmacological properties and therapeutic efficacy in cardiovascular disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of crossover trials to obtain antihypertensive dose-response curves and to study combination therapy during the development of benazepril

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New directions in antihypertensive drug therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of left ventricular hypertrophy under ramipril treatment investigated by nuclear magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of benazepril on ambulatory blood pressure, left ventricular mass, diastolic filling and aortic flow in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the antihypertensive effect of enalapril and propranolol in black South Africans

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of a new angiotensin-converting enzyme inhibitor, benazepril hydrochloride, in special populations

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Need for plasma angiotensin measurements to investigate converting-enzyme inhibition in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid measurement of total and active renin: plasma concentrations during acute and sustained converting enzyme inhibition with CGS 14824A

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blunting of atrial natriuretic factor response to volume expansion by benazepril in hypertensive patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of benazepril hydrochloride on cardiac hypertrophy in spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Converting enzyme inhibition in coronary artery disease: a randomized, placebo-controlled trial with benazepril

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse reactions with angiotensin converting enzyme (ACE) inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACE inhibitors in mild heart failure: first-line or second-line therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Arterial and endocrine effects of a combination of an angiotensin converting enzyme inhibitor and a vasodilator in normotensive healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin-converting enzyme inhibitors in the treatment of mild to moderate essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of benazepril, a new angiotensin-converting enzyme inhibitor, in mild to moderate essential hypertension: a multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoids Amplify Glomerular Injury in Rats with Renal Ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic implications of converting-enzyme inhibitors in renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of angiotensin II generation during converting enzyme inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Newer ACE inhibitors. A look at the future

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin-converting enzyme inhibitors. Emerging differences and new compounds

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of chronic administration of angiotensin converting enzyme (ACE) inhibitors on blood pressure and tissue ACE activity in the SHR

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal effects of enalapril in hypertensive patients with glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic therapy for congestive heart failure with benazepril HCl, a new angiotensin converting enzyme inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central and peripheral inhibition of angiotensin converting enzyme (ACE) in the SHR: correlation with the antihypertensive activity of ACE inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative inhibitory potency and plasma drug levels of angiotensin converting enzyme inhibitors in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter study of the safety and efficacy of benazepril hydrochloride, a long-acting angiotensin-converting enzyme inhibitor, in patients with chronic congestive heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitors (captopril, CGS14831 and CGS14824A) antagonise in vitro smooth muscle prostanoid synthesis: evidence for calcium channel blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of [14C]-benazepril hydrochloride in rat, dog and baboon. Absorption, distribution, kinetics, biotransformation and excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversing glomerular hypertension stabilizes established glomerular injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderly

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benazepril at incremental doses in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of two nonsulfhydryl angiotensin-converting enzyme inhibitors, CGS 14831 and CGS 16617, on myocardial damage and left-ventricular hypertrophy following coronary artery occlusion in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of enalapril on left ventricular mass and performance in essential hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1720384

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-199142030-00008

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36699417&oldid=2143846299"